Literature DB >> 401769

In vivo distribution of Pseudomonas aeruginosa slime glycolipoprotein: association with leukocytes.

M Lynn, J W Sensakovic, P F Bartell.   

Abstract

Intraperitoneal injection of slime glycolipoprotein (GLP) from Pseudomonas aeruginosa induced leukopenia and death of mice, similar to the effect of infection with viable organisms. Differential counts established that the leukopenia was characterized by a decrease in the number of polymorphonuclear leukocytes, followed by death of mice. Mice immunized with GLP survived challenge and responded with a leukocytosis that had a substantial increase in circulating polymorphonuclear leukocytes. Leukocytes from GLP-injected mice were agglutinated by anti-GLP serum, indicating an association between GLP and leukocytes. Other results indicated that 14C-labeled GLP is deposited mainly in the liver. Normal leukocytes labeled with 51Cr were injected intravenously into mice receiving an intraperitoneal injection of GLP. As with GLP, the 51Gr-labeled leukocytes were sequestered in the liver. These results indicate that GLP enters the blood stream and becomes associated mainly with neutrophils, and that the neutrophil-GLP complex is deposited in the liver, possibly accounting for the leukopenia in mice.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 401769      PMCID: PMC421335          DOI: 10.1128/iai.15.1.109-114.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  The nature and control of infections in patients with acute leukemia.

Authors:  E Frei; R H Levin; G P Bodey; E E Morse; E J Freireich
Journal:  Cancer Res       Date:  1965-10       Impact factor: 12.701

2.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  The distribution of chromium 51-labelled lymphoid cells in the mouse. A survey of anatomical compartments.

Authors:  M M Zatz; E M Lance
Journal:  Cell Immunol       Date:  1970-05       Impact factor: 4.868

4.  Purification and characterization of Pseudomonas aeruginosa exotoxin.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

5.  The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection.

Authors:  J W Sensakovic; P F Bartell
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

6.  Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report.

Authors:  M L Tapper; D Armstrong
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

7.  Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma.

Authors:  S C Schimpff; W H Greene; V M Young; P H Wiernik
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

8.  Biological activity of fragments derived from the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.

Authors:  J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

9.  Phagocytosis of live versus heat-killed bacteria by human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; D Mullikin; P S Shirley; C E McCall
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

10.  Slime of Pseudomonas aeruginosa: in vivo production.

Authors:  G Dimitracopoulos; J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  13 in total

1.  Effect of bacterial products on neutrophil migration in vitro.

Authors:  G Ras; R Wilson; H Todd; G Taylor; P Cole
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

2.  Phagocytosis and killing of Pseudomonas aeruginosa by mouse polymorphonuclear leukocytes in vitro promoted by antiserum to the slime glycolipoprotein.

Authors:  O Bishop; T Orr; P F Bartell
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

3.  Microscopic characterization of ocular damage produced by Pseudomonas aeruginosa toxin A.

Authors:  L D Hazlett; R S Berk; B H Iglewski
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

4.  Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.

Authors:  T Meshulam; H A Verbrugh; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1982-04       Impact factor: 3.267

5.  Phage-related surface modifications of Pseudomonas aeruginosa: effects on the biological activity of viable cells.

Authors:  G Dimitracopoulos; P F Bartell
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

6.  Microscopic characterization of rabbit lung damage produced by Pseudomonas aeruginosa proteases.

Authors:  L Gray; A Kreger
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

7.  Biochemical alterations in the mouse induced by Pseudomonas aeruginosa and its slime glycolipoprotein.

Authors:  M Lynn; L Lotz
Journal:  Br J Exp Pathol       Date:  1984-04

8.  Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice.

Authors:  J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

9.  Polysaccharide of the slime glycolipoprotein of Pseudomonas aeruginosa.

Authors:  L H Koepp; T Orr; P F Bartell
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

10.  Influence of anti-slime glycolipoprotein serum on the interaction between Pseudomonas aeruginosa and macrophages.

Authors:  P F Bartell; A Krikszens
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.